Illinois General Assembly - Bill Status for HB2468
Illinois General Assembly

Previous General Assemblies

 Bill Status of HB2468  96th General Assembly


Short Description:  IDPH-CANCER DRUG REPOSITORY

House Sponsors
Rep. Greg Harris - Karen May - Elizabeth Coulson - Susana A. Mendoza - Harry Osterman

Last Action
DateChamber Action
  1/11/2011HouseSession Sine Die

Statutes Amended In Order of Appearance
New Act
225 ILCS 85/4from Ch. 111, par. 4124
225 ILCS 120/15from Ch. 111, par. 8301-15
320 ILCS 50/10
410 ILCS 620/16from Ch. 56 1/2, par. 516
720 ILCS 570/102from Ch. 56 1/2, par. 1102
740 ILCS 20/3from Ch. 70, par. 903


Synopsis As Introduced
Creates the Cancer Drug Repository Program Act. Requires the Department of Public Health to establish a cancer drug repository program, under which any person may donate a cancer drug or supplies needed to administer a cancer drug for use by an individual who meets eligibility criteria specified by the Department. Sets forth requirements that cancer drugs or supplies must meet in order to be accepted and dispensed under the program. Provides that no drugs or supplies donated under the cancer drug repository program may be resold. Provides that nothing in the Act requires that a medical facility, pharmacy, pharmacist, or practitioner participate in the cancer drug repository program. Provides for civil and criminal immunity for drug and supply manufacturers and individuals in relation to the donation, acceptance, or dispensing of cancer drugs or supplies under the cancer drug repository program. Requires the Department to adopt certain rules to implement the cancer drug repository program. Amends the Pharmacy Practice Act of 1987, the Wholesale Drug Distribution Licensing Act, the Senior Pharmaceutical Assistance Act, the Illinois Food, Drug and Cosmetic Act, the Illinois Controlled Substances Act, and the Cannabis and Controlled Substances Tort Claims Act to provide that persons engaged in donating or accepting, or packaging, repackaging, or labeling, prescription drugs to the extent permitted or required under the Cancer Drug Repository Program Act are exempt from provisions of those other Acts that might prohibit or otherwise regulate such activity.

Actions 
DateChamber Action
  2/19/2009HouseFiled with the Clerk by Rep. Greg Harris
  2/19/2009HouseFirst Reading
  2/19/2009HouseReferred to Rules Committee
  2/20/2009HouseAdded Chief Co-Sponsor Rep. Karen May
  2/20/2009HouseAdded Chief Co-Sponsor Rep. Elizabeth Coulson
  2/20/2009HouseAdded Chief Co-Sponsor Rep. Susana A. Mendoza
  2/20/2009HouseAdded Chief Co-Sponsor Rep. Harry Osterman
  2/23/2009HouseAssigned to Human Services Committee
  3/13/2009HouseRule 19(a) / Re-referred to Rules Committee
  1/11/2011HouseSession Sine Die

Back To Top